Background & aims: Inflammatory bowel disease has considerable effects on work-related outcomes and leads to high societal costs due to sick leave and disability pension. The aims of this study were to systematically review evidence on work-related outcomes that are relevant to productivity losses and to evaluate whether medical or surgical interventions have a positive impact on patients' work ability. Methods: A systematic literature search in PubMed was conducted in June 2013. Abstracts were screened by two independent reviewers, and full-text articles describing the frequency of work-related outcomes were retrieved. Two independent reviewers extracted data according to the PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses. Findings were organized by study design (non-interventional/interventional). Non-interventional studies were structured according to whether they presented data in comparison to control groups or not and interventional studies were summarized according to type of intervention.
Introduction
Immune-mediated inflammatory disorders including Crohn's disease (CD) and ulcerative colitis (UC) have considerable effects on employment outcomes. 1 Many patients develop inflammatory bowel disease (IBD) at an early age which can result in high societal costs due to sick leave and disability pension. 2 To date, studies conducted on IBD and work outcome have primarily examined the occupational and socioeconomic distribution of the disease and productivity changes as a result of IBD. Little is known about the impact of interventions on labor force participation. However, increased knowledge about productivity losses could inform patients about prognosis and facilitate decisions about treatments. This is especially relevant as IBD is a chronic disorder and therefore social support is of paramount importance for patients to continue active labor force participation.
Previous reviews have been limited in that they only included work-related outcomes as part of an overall summary of the disease burden, [1] [2] [3] [4] [5] [6] [7] [8] provided information for specific countries and/or included IBD as part of a review on the burden of immune-mediated inflammatory diseases. 1, 3, 6, 7 In the current review burden is defined as the cumulative consequence of IBD compared to the state in a healthy person. One review 9 focusing solely on the education and employment behavior in IBD was not systematic and did not include recently published reports. [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] Furthermore, studies investigating the effect of specific interventions on work outcomes have not yet been summarized. [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] The aim of this study was to perform a systematic review of published studies on domains of work participation that are relevant for the quantification of productivity 1375 
Methods

Literature search and data synthesis
A systematic search was conducted in PubMed MEDLINE and EMBASE 47 in June 2011 and was updated in June 2013 (KB, MH). Search terms included combinations of 'Crohn's disease', 'ulcerative colitis', 'inflammatory bowel disease' and '(un-) employment', 'sick leave', 'absenteeism', 'work loss', 'productivity loss', 'disability pension' or 'early retirement' (detailed search strategy is available upon request from the corresponding author). Besides the requirement to include full-text articles published in English, no further restrictions were applied.
For the initial screening, abstracts were screened by two independent reviewers (KB and SAdS). Full-text articles were retrieved if abstracts included information on work-related outcomes such as employment status, work capacity, sick leave, disability pension or early retirement in adults and if publications were reviews, comments or editorials. Exclusion criteria included non-IBD related research or animal research, pediatric populations, no reported work-related outcomes, case reports, study protocols or interventions not of interest (e.g. nursing interventions).
To complement the database search, the reference lists of included studies and review articles were screened to identify additional studies using publication titles (KB). Figure 1 Flowchart of study selection and inclusion. *Articles only counted in one of the exclusion groups, even though articles could be excluded for N 1 reason; IBD = inflammatory bowel disease. Two studies of the 45 included manuscripts were included in both -the non-interventional and interventional -sections as they reported results for IBD patients alone or in comparison to matched controls and results for surgical interventions. A flowchart describing the article search process is depicted in Fig. 1 .
Notes to
38,46
Data extraction was performed by at least two independent reviewers (KB and SAdS; in case of questions review by MH and/or FMR) taking the PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses into account. 48 Outcomes included employment status, work capacity, sick leave, disability pension, early retirement and the Work Productivity and Activity Impairment: Crohn's Disease (WPAI: CD). The WPAI is a validated, self-administered questionnaire assessing the impact of CD on the patient's ability to work and/or perform non-work activities. 49 Results of the WPAI are expressed as a percentage of impairment, with higher percentages indicating greater impairment and less productivity. The results include four scores: percentage of time work missed (absenteeism), percentage of impairment while working (presenteeism), percentage of activity impairment (total work productivity impairment; TWPI), and an overall percentage work impairment score (total activity impairment; TAI). Original studies describing the frequency of work-related outcomes in patients with CD, UC or IBD were included. Papers which did not report outcome frequencies or reported incomplete/insufficient denominator information were excluded. [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] The findings were organized by study design (noninterventional/interventional). Non-interventional studies were then structured according to whether they presented data in comparison to control groups or not and interventional studies were structured according to type of intervention. Whenever possible, a comparison of outcomes was made between two groups (IBD patients and controls) or two time points (before and after intervention).
Direct comparisons and pooling of effect estimates by use of meta-analysis was not attempted due to heterogeneity between studies. The main reasons for variations between studies were differences in definitions used for CD/UC (e.g. based on ICD codes, case history or endoscopy results, Lennard-Jones criteria for CD) and outcome measures such as employment or working status, sick leave and/or disability pension. Additionally there were differences between populations investigated (e.g. socioeconomic status), differences in the observation period, and variations in assessment of both exposure and work-related outcomes (e.g. register excerpts versus interviews). Therefore only narrative summaries are provided.
Results
A total of 112 studies were identified after the electronic search. Based on information in the abstracts 44 studies were excluded. Sixty-eight articles were then selected for full-text review and their reference lists were screened for additional articles using publication titles (Fig. 1) . Hand searching by title led to the identification and review of 32 additional articles. Of those, 9 were included while 23 were excluded. In total, 30 non-interventional and 17 interventional studies formed the basis of this review.
Non-interventional studies
Thirty non-interventional studies provided information on ≥ 1 work-related outcome of interest. Fifteen studies compared work-related outcomes in the patient population(s) to matched (Table 1) or unmatched controls (Table 2 ). Another 15 studies described work outcomes in IBD only (Table 3 ). All non-interventional studies were categorized according to outcome investigated.
Employment status
Three studies provided information on the number of patients being employed in the IBD, UC or CD groups compared to their matched controls (Table 1) . 10, 60, 61 When compared to ageand sex-matched controls, employment was lower in patients compared to controls. 60 However, when the comparison was made to age-and sex-matched controls, who had been admitted to a hospital for acute conditions, similar employment frequencies were observed (65% of CD patients versus 64% of controls 61 and 71% of UC patients versus 73% of controls were employed). 10 All studies involving unmatched comparator groups reported a lower number of IBD patients being employed or part of the labor force compared to the comparator groups (Table 2) . 24, 62, 63, 11, 62, 64, 65 The difference became more evident in IBD patients with symptoms when compared to IBD patients without symptoms or controls. Overall, the IBD population with symptoms was more than two times as likely as the non-IBD population to be out of the labor force (OR = 2.14). 64 Similar to the studies that included comparator groups, the papers solely describing IBD, UC or CD patients showed high, but varying frequencies in employment (65%-73% in IBD, 48%-73% in CD and 61%-79% in UC; Table 3 ). 13, 25, 28, 38, 66 3.1.2. Sick leave While in two studies sick leave which was defined as b 11 days was similar between CD or UC patients and their matched controls, 10,61 a register based study showed that a significantly higher proportion of UC patients had a documented sick leave of N 14 days paid by the Social Insurance Agency (SIA) when compared to matched controls (Table 1) . 46 Studies without comparison groups showed similar and also lower values for the frequency of sick leave in IBD patient populations (10%-51% for CD and 8%-40% for UC; Table 3) . 23, 25, 38 3.1.3. Work disability All studies using a matched control design, reported a higher frequency of work disability in IBD, UC or CD patients compared to the matched comparator groups (Table 1) . 46, 60, 15 Those findings are supported by the majority of studies compared to non-matched comparators, who showed that more IBD, UC or CD patients were disabled or receive pension (Table 2) . 11, 16, 18 Nevertheless, one study reported a lower frequency of patients being disabled or on disability pension compared to the general population. 62 
Early retirement
Only one study compared patients to age-and sex-matched controls and reported that 0% of CD and 3% of UC patients versus 3% of controls were on early retirement (Table 1) . 60 Two additional studies evaluated early retirement in IBD patients only and reported that 4% of CD and 5% of UC patients 25 and 7% of IBD 28 patients were retired or had early retirements (Table 3) . 
Unemployment
While studies comparing unemployment rates in IBD, UC or CD patients compared to matched controls found no or minor differences between the groups (Table 1) , 61,10,60 studies which reported unemployment compared to the general population found greater differences (4% of the general population versus 11%-12% of IBD, 4%-12% of CD, and 11%-13% of UC patients). 11, 12, 62 Especially, IBD patients experiencing symptoms were at higher risk of not being part of the labor force compared to patients without symptoms (Table 2) . 64 Higher frequencies of unemployment were reported in two CD specific studies which reported up to 45% of CD patients being unemployed (Table 3) . 13, 14 
Interventional studies
Of 17 studies, nine reviewed surgical interventions (Table 4) , [38] [39] [40] [41] [42] [43] [44] [45] [46] while eight investigated the impact of biologic treatment on work outcomes in IBD patients (Table 5 ).
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Surgical interventions for IBD
Of nine studies describing work-related outcomes in patients with IBD-related surgery, six studies examined outcomes after surgery only. [38] [39] [40] [41] [42] 45 Three studies investigated normal work capacity, disability or retirement before and after surgical intervention (Table 4) . 43 before and after mucosal proctectomy and ileal J-pouch-anal anastomosis in 49 UC patients (median follow-up time after surgery was 42 months). The proportion of subjects with normal capacity to work increased from 12% pre-operatively to 94% post-operatively. 43 Two Swedish studies came to the conclusion that 81% of UC subjects and 69%-73% of CD subjects reported normal work capacity after surgery. 39, 40 3.2.1.3. Retirement/disability pension. Between 4% and 6% of IBD patients retired prematurely or were fully disabled after surgery. 38, 39 The percentage was slightly higher in a study in CD patients (7% were on disability pension after primary excisional surgery) 40 compared to a study in UC patients (5% of UC patients were on disability pension after restorative proctocolectomy). 45 Two studies evaluated the impact of surgery on retirement and disability pension in UC patients. One found a 50% increase in the proportion of patients being fully disabled after colectomy. 46 The other reported similar number of patients being retired before and after surgery, but noted a higher number of patients retiring after conventional proctocolectomy when compared to restorative proctocolectomy. 44 3.2.1.4. Other work-related outcomes. Temporary sick leave due to CD during the follow-up period after surgery was reported by 5% of patients. 40 A change in job was reported in 10% to 13% of IBD patients 38, 39 and 13% had to modify their work/hours. 38 Lighter work was sought for by 3% of IBD patients. 38 
Medical treatment for IBD
Eight studies investigated work-related outcomes in UC 30 and CD [31] [32] [33] [34] [35] [36] [37] patients with biologic treatment. All studies used self-reported outcome measures with six using the WPAI:CD questionnaire (Table 5) . [32] [33] [34] [35] [36] [37] 3.2.2.1. Employment status. Most studies reported only baseline data regarding employment status, with the number of employed patients varying between 55% and 65%. [30] [31] [32] [33] [34] [35] [36] One of the eight studies reported a positive effect on employment status after 24 weeks of treatment (64% of UC patients employed at baseline versus 69% at the end of study). 35 Lichtenstein et al. provided employment information by remission status for 162 CD patients who were unemployed at baseline and had data at week 54. Of the 58 patients in remission 31% were employed at week 54 compared to 16% among the 104 CD patients not in remission. 31 
WPAI scores.
Six studies reported significant changes in WPAI scores from baseline to end of study. [32] [33] [34] [35] [36] [37] Reduction in the mean absenteeism score ranged from − 7 to − 15, in the mean presenteeism score from − 15 to − 20 and in the mean TWPI score from − 19 to − 21 in the employed patient population. All five RCTs reported also significant improvements in mean TAI score from baseline (mean change from − 19 to − 28). [32] [33] [34] [35] [36] 3.2.2.3. Work outcomes. Reinisch et al. calculated hours per week actually worked (HPWAW), productivity and hours per week fully productive (HPWFP) to evaluate work and productivity of UC patients. HPWFP was calculated as HPWAW × productivity score / 100. At week 30, greater improvements were seen for all three outcomes in patients in remission compared with those UC patients not in remission. 30 
Discussion
This systematic review of published articles quantifies the frequency of work-related outcomes in IBD (and specifically in UC and CD), and summarizes the effect of surgical and medical interventions on work-related outcomes.
Compared with the review by Marri et al. published in 2005, 9 which investigated education and employment behavior in IBD patients, the current systematic review included 13 studies that were not identified 10, 13, 18, 19, 22, 31, [39] [40] [41] [42] [43] [44] [45] and 24 studies published after 2005. 11, 12, [14] [15] [16] [17] 20, 21, [23] [24] [25] [26] [27] [28] [29] [30] [32] [33] [34] [35] [36] [37] 46, 67 In addition, all studies that investigated the effect of surgical or medical interventions on work outcomes were summarized. [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] Similar to Marri et al. 9 this review found that the majority of studies report an increased frequency of sick leave, disability pension and unemployment in IBD. Furthermore, it was found that medical treatment, defined as biologic agents, seems to have a positive effect on absenteeism and presenteeism in randomized clinical trials. [32] [33] [34] [35] [36] [37] However, the impact of medical interventions over a longer follow-up and other outcomes such as employment and disability pension as well as the impact of surgical interventions need further evaluation.
Strengths and limitations
This is the first paper systematically summarizing information regarding frequency of employment status, sick leave, working capacity, disability pension and early retirement in IBD, UC and CD patients including medical and surgical interventions and their effect on different work-related outcomes. Our extensive literature review enabled us to identify a number of areas where additional research is needed. These include interventions and their impact on work-related outcomes and risk factors impacting workrelated outcomes in patients with IBD. Evidence of an impact of medical and surgical intervention on work-related outcomes in IBD patients is limited. Medical interventions have so far only been evaluated in specifically defined patient groups included in clinical trials with a short duration (20-54 weeks) 31, 36 not allowing for extrapolation. Most papers reviewing surgical interventions are small in size (49-136 participants) 40, 43 and are based on self-reported information potentially affected by both non-response and recall bias. The resulting imprecision in estimates and uncertainty of the generalizability of the findings is therefore substantial. Additional robust data is needed to better understand whether medical treatment could restore work ability to the level of the general population, or in case of surgical intervention even to pre-surgery levels. In addition, a better understanding of risk factors interacting to create work limitations and work loss is required to better guide early interventions for individual patients to prevent or at least postpone work disability and job loss.
Several limitations are acknowledged including the fact that pooling of effect estimates was not possible due to great heterogeneity between studies regarding definition of IBD, definition of outcomes, study population, study design and outcome measurement. Those differences in study design and methods could explain parts of the observed variation in results. Additional reasons, which could have influenced work outcomes and therefore results reported, could be differences and changes in legislations, labor market flexibilities at the time of the study or different social security systems influencing patient work motivation. 68, 69 For instance, the official unemployment rate in the Netherlands (Eurostat, accessed Jan 8, 2014) at the time of the Boonen et al. 60 study was 2-3%, as compared with above 8% in 1984. It is therefore important that data on IBD cases and controls are obtained simultaneously. Cyclical and structural changes in the labor market will otherwise bias the results, and natural changes may also explain the differences in e.g. unemployment rates over time within and between countries.
Methodological challenges with studies included
As mentioned above, it is important to consider a number of factors when reviewing studies of work-related outcomes. For example, one issue mentioned is the limiting comparability concerning the study populations. While some studies reported work-related outcomes for those in working age (19-64 years), 11, 46 others restricted the analysis to those being employed. 37 In addition, some studies selected subgroups to report different outcomes (e.g. results on sick leave and presenteeism were reported for those employed or in working age), 28, [32] [33] [34] [35] [36] [37] 46 while measures on employment status were often reported for the total group. Another issue is the differences in comparator groups impacting comparability of results (some studies matched for age and sex, 10, 60, 61 others for propensity score 15 ). In the studies using unmatched comparator groups, the comparison was made with the general population or general population controls as well as with unmatched non-IBD, healthy, buddy or community controls. 11, 12, [16] [17] [18] 24, [62] [63] [64] [65] Comparability of results is also limited by different definitions of IBD. Some papers used self-reported information, 64, 65 while others used case history and endoscopic result or ICD codes to classify patients. 10, 40, 46, 60, 62 Other papers did not provide a definition of IBD or their outcome. Others used a wide range of methods and definitions (eg. registers from social insurance agencies, 46 ,60 self-composed questionnaires or validated instruments such as the WPAI) [32] [33] [34] [35] [36] [37] thus comparability remains limited. Finally, most studies used different definitions to describe work-related outcomes. For example, definition of work status ranged from working (including also students), 26 labor force participation (considered all individuals who were unemployed, 11 all unemployed individuals who were actively seeking work 62 or all having worked for pay or profit at any time in the past 12 months), 64, 65 being employed (defined as full-time, part-time 20, 27, 60 and/or self-employment) 38 to working actively (defined as being employed and not being on sick leave). 23, 24 The resulting significant heterogeneity between studies made an interpretation of results difficult. Therefore, to enhance comparability between studies, consensus on outcome instruments and on how to conduct and report studies on work-related outcomes is needed. 68 However, an unequivocal definition of those outcomes is difficult and measurements may not be sufficient to capture the real burden. 7, 62 For example, employment as an outcome variable would not be sufficient as a higher percentage of IBD patients are at home and not actively in the labor force. 62 In addition, sick leave is restricted to labor force participants. This will lead to selection bias, as the sickest and most vulnerable individuals never enter the labor market and never run the risk of sick leave. 69 
Conclusion
The majority of studies have found that patients with IBD experience a high burden in work-related outcomes regardless of the methodology used to measure and quantify these outcomes. While biologic agents showed positive effect on absenteeism and presenteeism in randomized clinical trials, the impact of surgical interventions needs further evaluation.
In conclusion, additional data on productivity losses and long-term impact of interventions is needed to help inform decisions about treatment options and their benefits in reducing loss of economic productivity and work disability.
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